MoneyWorks4Me

Genpharmasec - Quaterly Results

21 May 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 135.56 millions rose by 32.91% from Rs. 101.99 millions.The Net Loss for the quarter ended March 2025 is Rs. -2.27 millions as compared to Net Loss of Rs. -0.51 millions of corresponding quarter ended March 2024Operating profit for the quarter ended March 2025 decreased to 0.64 millions as compared to 4.73 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 135.56 101.99 32.91 329.64 304.06 8.41 329.64 304.06 8.41
Other Income 10.60 3.11 240.84 34.28 7.18 377.44 34.28 7.18 377.44
PBIDT 0.64 4.73 -86.47 38.58 8.78 339.41 38.58 8.78 339.41
Interest 0.60 1.42 -57.75 2.78 3.95 -29.62 2.78 3.95 -29.62
PBDT 0.04 3.31 -98.79 35.80 4.83 641.20 35.80 4.83 641.20
Depreciation 0.40 0.04 900.00 1.33 0.17 682.35 1.33 0.17 682.35
PBT -0.36 3.27 -111.01 34.47 4.66 639.70 34.47 4.66 639.70
TAX 1.91 3.78 -49.47 9.78 4.20 132.86 9.78 4.20 132.86
Deferred Tax -0.64 3.78 -116.93 2.90 4.20 -30.95 2.90 4.20 -30.95
PAT -2.27 -0.51 345.10 24.69 0.46 5267.39 24.69 0.46 5267.39
Equity 553.72 553.72 0.00 553.72 553.72 0.00 553.72 553.72 0.00
PBIDTM(%) 0.47 4.64 -89.82 11.70 2.89 305.31 11.70 2.89 305.31
Peers